M&A Deal Summary |
|
|---|---|
| Date | 2012-10-05 |
| Target | Metrics |
| Sector | Life Science |
| Buyer(s) | Mayne Pharma |
| Deal Type | Add-on Acquisition |
| Deal Value | 120M USD |
SEARCH BY
| Category | Company |
|---|---|
| Sector | Life Science |
| Employees | 491 |
| Revenue | 388M AUD (2024) |
Mayne Pharma is a specialty pharmaceutical company that develops and manufactures branded and generic products, which it distributes globally, either directly or through distribution partners and also provides contract development and manufacturing services. Mayne Pharma is based in Salisbury South, Australia.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 4 |
| Sector: Life Science M&A | 2 of 4 |
| Type: Add-on Acquisition M&A Deals | 2 of 3 |
| State: North Carolina M&A | 1 of 1 |
| Country: United States M&A | 1 of 3 |
| Year: 2012 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-10-30 |
FH Faulding & Co.
Salisbury South, Australia FH Faulding & Co., Ltd. is a developer of pharmaceuticals products and offers contract manufacturing services. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-07-02 |
Libertas Pharma
Lawrenceville, Georgia, United States Libertas Pharma Inc. is a generic pharmaceutical company that distributes and markets a range of niche products in the US. |
Buy | - |